366 related articles for article (PubMed ID: 7638771)
1. [The efficacy of an erythropoietin-calcitriol combination in patients with chronic kidney failure on programmed hemodialysis].
Nikolaev AIu; Klepikov PV; Lashutin SV; Kukhtevich AV
Ter Arkh; 1995; 67(5):27-31. PubMed ID: 7638771
[TBL] [Abstract][Full Text] [Related]
2. [The use of recombinant erythropoietin with patients on programmed hemodialysis].
Rozental' RL; Zezina LIu; Spudass AV
Ter Arkh; 1991; 63(12):110-3. PubMed ID: 1803587
[TBL] [Abstract][Full Text] [Related]
3. [The effect of recombinant human erythropoietin during hemodialysis on the thrombocyte and erythrocyte functions of patients with chronic kidney failure].
Rud'ko IA; Balashova TS; Kubatiev AA; Ermolenko VM
Ter Arkh; 1994; 66(6):57-60. PubMed ID: 7940371
[TBL] [Abstract][Full Text] [Related]
4. Effect of recombinant human erythropoietin on the anemia of chronic renal failure.
Urabe A; Takaku F; Mizoguchi H; Kubo K; Ota K; Shimizu N; Tanaka K; Mimura N; Nihei H; Koshikawa S
Int J Cell Cloning; 1988 May; 6(3):179-91. PubMed ID: 3397592
[TBL] [Abstract][Full Text] [Related]
5. [Calcitriol: role in the regulation of erythropoiesis, use in the treatment of renal anemia].
Nikolaev AIu; Klepikov PV; Lashutin SV; Kukhtevich AV
Vestn Ross Akad Med Nauk; 1995; (5):39-43. PubMed ID: 7626984
[TBL] [Abstract][Full Text] [Related]
6. [The comparative characteristics of parlodel, zinc sulfate and recombinant erythropoietin in treating uremic hypogonadism in patients on chronic hemodialysis].
Kukhtevich AV; Ermolenko VM; Dedov II; Gitel' EP; Buniatian AF; Smirnova GA
Ter Arkh; 1992; 64(11):66-70. PubMed ID: 1293848
[No Abstract] [Full Text] [Related]
7. [Recent findings on the pathogenesis and therapy of anemia in chronic kidney failure].
Moccia F; Morra L; Gurreri G
Recenti Prog Med; 1992 Oct; 83(10):572-6. PubMed ID: 1462041
[TBL] [Abstract][Full Text] [Related]
8. [Some aspects of current treatment of patients with terminal chronic renal insufficiency].
Burtsev VI; Grankin VI; Briukhovetskiĭ AG; Klopotskiĭ SA; Miasnikova EB
Klin Med (Mosk); 1993 Jan; 71(1):33-6. PubMed ID: 8046902
[TBL] [Abstract][Full Text] [Related]
9. Nutritional assessment in anemic hemodialysis patients treated with recombinant human erythropoietin.
Bárány P; Pettersson E; Ahlberg M; Hultman E; Bergström J
Clin Nephrol; 1991 Jun; 35(6):270-9. PubMed ID: 1873941
[TBL] [Abstract][Full Text] [Related]
10. [The effect of recombinant human erythropoietin on thrombocyte aggregation capacity and on the blood prostanoid level in patients with chronic kidney failure on hemodialysis].
Rud'ko IA; Pokrovskiĭ IuA; Ermolenko VM; Kubatiev AA
Ter Arkh; 1991; 63(10):128-30. PubMed ID: 1805410
[TBL] [Abstract][Full Text] [Related]
11. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
Brandi L
Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
[TBL] [Abstract][Full Text] [Related]
12. [The importance of erythropoietin in the therapy of anemia in patients on chronic hemodialysis].
von Appen K; Klinkmann H
Urol Nefrol (Mosk); 1990; (6):69-70. PubMed ID: 2089771
[No Abstract] [Full Text] [Related]
13. Effects of erythropoietin in predialysis patients.
Anderson S
Am J Kidney Dis; 1991 May; 17(5 Suppl 1):103-6. PubMed ID: 2024665
[No Abstract] [Full Text] [Related]
14. Maintenance therapy with intravenous iron in hemodialysis patients receiving erythropoietin.
Kotaki M; Uday K; Henriquez M; Blum S; Dave M
Clin Nephrol; 1997 Jul; 48(1):63-4. PubMed ID: 9247787
[No Abstract] [Full Text] [Related]
15. [The effect of calcitriol on renal anemia in patients under chronic hemodialysis].
Abou-Khalil N; Makó J
Orv Hetil; 1996 Jul; 137(27):1469-72. PubMed ID: 9173368
[TBL] [Abstract][Full Text] [Related]
16. [Treatment of anemia in chronically dialyzed patients].
Moynot A
Nephrologie; 1998; 19(3):125-7. PubMed ID: 9633055
[No Abstract] [Full Text] [Related]
17. The effect of i.v. iron alone or in combination with low-dose erythropoietin in the rapid correction of anemia of chronic renal failure in the predialysis period.
Silverberg DS; Blum M; Agbaria Z; Deutsch V; Irony M; Schwartz D; Baruch R; Yachnin T; Steinbruch S; Iaina A
Clin Nephrol; 2001 Mar; 55(3):212-9. PubMed ID: 11316241
[TBL] [Abstract][Full Text] [Related]
18. [Status epilepticus in chronically dialyzed patients treated with erythropoietin].
Massetani R; Galli R; Calabrese R; Sartucci F; Rindi P; Severino Brandi L; Murri L
Riv Neurol; 1991; 61(6):215-8. PubMed ID: 1813973
[TBL] [Abstract][Full Text] [Related]
19. Orally administrated Juzen-taiho-to/TJ-48 ameliorates erythropoietin (rHuEPO)-resistant anemia in patients on hemodialysis.
Nakamoto H; Mimura T; Honda N
Hemodial Int; 2008 Oct; 12 Suppl 2():S9-S14. PubMed ID: 18837771
[TBL] [Abstract][Full Text] [Related]
20. Effects of erythropoietin on strength and functional status of patients on hemodialysis.
Guthrie M; Cardenas D; Eschbach JW; Haley NR; Robertson HT; Evans RW
Clin Nephrol; 1993 Feb; 39(2):97-102. PubMed ID: 8448925
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
